Since August 2021, Moderna’s stock has been in a downtrend.
The latest decline started in May 2024 and ended in April 2025, dropping from 170 to 23.
Since April 2025, a corrective move has begun for one of the sub-waves.
This move is nearly complete, with final targets at 36 -> 38.
This does not mean the uptrend is over - after some time and additional corrections, we should see a move toward 57.
The longer-term outlook remains clear and largely positive.
For now, let's focus on the targets mentioned. Further developments will be shared in new ideas.
---
Please subscribe and leave a comment.
You’ll get new information faster than anyone else.
---
The latest decline started in May 2024 and ended in April 2025, dropping from 170 to 23.
Since April 2025, a corrective move has begun for one of the sub-waves.
This move is nearly complete, with final targets at 36 -> 38.
This does not mean the uptrend is over - after some time and additional corrections, we should see a move toward 57.
The longer-term outlook remains clear and largely positive.
For now, let's focus on the targets mentioned. Further developments will be shared in new ideas.
---
Please subscribe and leave a comment.
You’ll get new information faster than anyone else.
---
交易結束：目標達成
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。